| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |